Cargando…

Nasal Nitric Oxide Levels in HIV Infection: A Cross-Sectional Study

INTRODUCTION: Low levels of nasal NO have been associated with increased propensity to rhinosinusitis and respiratory tract infections. Our objective was to describe nasal NO levels in HIV-infected individuals versus healthy controls and determine possible risk factors for reduced nasal NO levels. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costiniuk, Cecilia T., Mehraj, Vikram, Routy, Jean-Pierre, de Castro, Christina, Wasef, Natale, Jenabian, Mohammad-Ali, Salahuddin, Syim, Lebouché, Bertrand, Cox, Joseph, Szabo, Jason, Klein, Marina, Lands, Larry, Shapiro, Adam J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818882/ https://www.ncbi.nlm.nih.gov/pubmed/29552357 http://dx.doi.org/10.1155/2018/7645125

Ejemplares similares

The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection
por: Mehraj, Vikram, et al.
Publicado: (2016)

Interleukin-1β Triggers p53-Mediated Downmodulation of CCR5 and HIV-1 Entry in Macrophages through MicroRNAs 103 and 107
por: Lodge, Robert, et al.
Publicado: (2020)

Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2016)

Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation
por: Costiniuk, Cecilia T, et al.
Publicado: (2019)

HIV persistence in mucosal CD4(+) T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy
por: Costiniuk, Cecilia T., et al.
Publicado: (2018)

Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross‐sectional study
por: Costiniuk, CT, et al.
Publicado: (2019)

The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research
por: Mehraj, Vikram, et al.
Publicado: (2017)

Socio‐economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015
por: Mehraj, Vikram, et al.
Publicado: (2018)

HIV-Infected Macrophages Are Infected and Killed by the Interferon-Sensitive Rhabdovirus MG1
por: Sandstrom, Teslin S., et al.
Publicado: (2021)

Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy
por: Mehraj, Vikram, et al.
Publicado: (2014)

HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
por: Vyboh, Kishanda, et al.
Publicado: (2015)

The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter in People with HIV: A Pilot Study
por: Sebastiani, Giada, et al.
Publicado: (2022)

Cytomegalovirus Seropositivity Is Associated With Increased Microbial Translocation in People Living With Human Immunodeficiency Virus and Uninfected Controls
por: Ramendra, Rayoun, et al.
Publicado: (2019)

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection
por: Mehraj, Vikram, et al.
Publicado: (2019)

The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy
por: Routy, Jean-Pierre, et al.
Publicado: (2016)

Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032)
por: Isnard, Stéphane, et al.
Publicado: (2022)

Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
por: Costiniuk, Cecilia T., et al.
Publicado: (2020)

FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
por: Yero, Alexis, et al.
Publicado: (2022)

Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028) †
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2022)

HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation
por: Allam, Ossama, et al.
Publicado: (2018)

Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2023)

Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests
por: Mehraj, Vikram, et al.
Publicado: (2015)

Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design
por: Routy, Jean-Pierre, et al.
Publicado: (2017)

HIV Infection and Persistence in Pulmonary Mucosal Double Negative T Cells In Vivo
por: Meziane, Oussama, et al.
Publicado: (2020)

Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection
por: Alexandrova, Yulia, et al.
Publicado: (2022)

A79 THE RELATIONSHIP BETWEEN VISCERAL ADIPOSITY AND NONALCOHOLIC FATTY LIVER DISEASE DIAGNOSED BY CONTROLLED ATTENUATION PARAMETER IN PEOPLE WITH HIV: A PILOT STUDY
por: Elgretli, W, et al.
Publicado: (2023)

Dynamics and epigenetic signature of regulatory T-cells following antiretroviral therapy initiation in acute HIV infection
por: Yero, Alexis, et al.
Publicado: (2021)

The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune Response
por: Mehraj, Vikram, et al.
Publicado: (2016)

The grace of aging with ART: Ex vivo dendritic cell-based immunotherapy restores HIV-specific functional CD8(+) T-cells
por: Mehraj, Vikram, et al.
Publicado: (2022)

Angiocentric lymph proliferative disorder (lymphomatoid granulomatosis) in a person with newly-diagnosed HIV infection: a case report
por: Costiniuk, Cecilia T., et al.
Publicado: (2018)

The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy – CTN PT006: study protocol for a randomized controlled trial
por: Lebouché, Bertrand, et al.
Publicado: (2014)

Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study
por: Royston, Léna, et al.
Publicado: (2023)

Use of various immunotherapies for refractory ulcerative colitis in a person living with HIV: a case report
por: Costiniuk, Cecilia T, et al.
Publicado: (2021)

Evaluation of a project to engage patients in the development of a patient‐reported measure for HIV care (the I‐Score Study)
por: Lessard, David, et al.
Publicado: (2018)

Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort
por: Cinque, Felice, et al.
Publicado: (2023)

Nasal Nitric Oxide Is Correlated With Nasal Patency and Nasal Symptoms
por: Ren, Lei, et al.
Publicado: (2019)

Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection
por: Benmassaoud, Amine, et al.
Publicado: (2018)

Limitations of Nasal Nitric Oxide Testing in Primary Ciliary Dyskinesia
por: Shapiro, Adam J., et al.
Publicado: (2020)

Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era
por: Cao, Wei, et al.
Publicado: (2016)

Concurrent HIV viral blips during two episodes of multicentric Castleman disease in an adult on antiretroviral therapy: Implication for HIV persistence
por: Darwish, Ilyse, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dqjdd90tpna4m1997tbmg7vo45